|Table of Contents|

The biological function of MND1 and its research progress in tumor development

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 21
Page:
4177-4182
Research Field:
Publishing date:

Info

Title:
The biological function of MND1 and its research progress in tumor development
Author(s):
LI HuiqingPANG ZhenfeiLIU ShuangLI Nan
School of Basic Medicine,Jiamusi University,Key Laboratory of Microecology-Immunomodulatory Network and Related Diseases,School of Basic Jiamusi University Medicine,Heilongjiang Jiamusi 154007,China.
Keywords:
MND1tumourcell cycleresearch progress
PACS:
R730
DOI:
10.3969/j.issn.1672-4992.2024.21.030
Abstract:
Uncontrolled cell cycle progression is a significant sign of abnormal tumor proliferation.Cell cycle-related gene changes can cause cell-cycle disorder,resulting in uncontrolled cell division,an essential reason for promoting tumor cell growth.Breaking the endogenous homeostasis of tumor cell cycle-related factors may lead to abnormal cell proliferation and tumor formation.The meiosis factor may be an essential target for tumor therapy and biomonitoring.Few studies have been conducted on meiotic nuclear divisions 1(MND1),but more and more reports have been reported on the critical role of MND1 in tumor development.The abnormal expression of MND1 in various tumors is closely related to the occurrence and development of tumors.In this paper,the biological function of MND1 in tumors and the relationship between MND1 and tumor development are reviewed,which is helpful to analyze further the mechanism of action of this gene in tumors.

References:

[1]奇云.2001年诺贝尔生理学或医学奖介评三位科学家与三种神秘物质[J].科学对社会的影响,2001,20(4):12-15.QI Y.The 2001 Nobel Prize in Physiology or Medicine was awarded to three scientists and three mysterious substances[J].The Impact of Science on Society,2001,20(4):12-15.
[2] 韦伟,龚建平,裘法祖.细胞周期调控与肿瘤的发生发展[J].癌症,1999,18(1):95-97.WEI W,GONG JP,QIU FZ.Cell cycle regulation and tumor development[J].Cancer,1999,18(1):95-97.
[3] ISHIGURO KI,MATSUURA K,TANI N,et al.MEIOSIN sirects the switch from mitosis to meiosis in mammalian germ cells[J].Dev Cell,2020,52(4):429-445.
[4] LI Q,QING L,XU W,et al.Berberine affects the proliferation,migration,invasion,cell cycle,and apoptosis of bladder cancer cells T24 and 5637 by down-regulating the HER2/PI3K/AKT signaling pathway[J].Arch Esp Urol,2023,76(2):152-160.
[5] CRICKARD JB,KWON Y,SUNG P,et al.Dynamic interactions of the homologous pairing 2(Hop2)-meiotic nuclear divisions 1(Mnd1) protein complex with meiotic presynaptic filaments in budding yeast[J].J Biol Chem,2019,294(2):490-501.
[6] TSUBOUCHI H,ROEDER GS.The Mnd1 protein forms a complex with hop2 to promote homologous chromosome pairing and meiotic double-strand break repair[J].Mol Cell Biol,2002,22(9):3078-3088.
[7] GAJIWALA KS,BURLEY SK.Winged helix proteins[J].Curr Opin Struct Biol,2000,10(1):110-116.
[8]KANG HA,SHIN HC,KALANTZI AS,et al.Crystal structure of Hop2-Mnd1 and mechanistic insights into its role in meiotic recombination[J].Nucleic Acids Res,2015,43(7):3841-3856.
[9]TSUBOUCHI H.The Hop2-Mnd1 complex and its regulation of homologous recombination[J].Biomolecules,2023,13(4):662.
[10]ZIERHUTC,BERLINGER M,RUPP C,et al.Mnd1 is required for meiotic interhomolog repair[J].Curr Biol,2004,14(9):752-762.
[11]余雨杨,侯凯龙,仝津恺,等.有丝分裂期DNA合成(MiDAS)及其介导的端粒复制[J].生物化学与生物物理进展,2022,49(10):1918-1926.YU YY,HOU KL,TONG JK,et al.Mitotic DNA synthesis(MiDAS) and its mediated telomere replication[J].Advances in Biochemistry and Biophysics,2022,49(10):1918-1926.
[12]CHEN J,GUANUIZO A,LUONG Q,et al.Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium[J].Oncogene,2022,41(1):138-145.
[13]LAPKINA EZ,ESIMBEKOVA AR,BELENIUK VD,et al.The distribution of B16 melanoma cells in cell-cycle phases under the influence of dacarbazine[J].Cell and Tissue Biology,2023,17(2):161-168.
[14]LIU Y,GU W.The complexity of p53-mediated metabolic regulation in tumor suppression[J].Semin Cancer Biol,2022,85:4-32.
[15]ZHANG Q,SHI R,BAI Y,et al.Meiotic nuclear divisions 1(MND1) fuels cell cycle progression by activating a KLF6/E2F1 positive feedback loop in lung adenocarcinoma[J].Cancer Commun(Lond),2021,41(6):492-510.
[16] ENGELAND K.Cell cycle regulation:p53-p21-RB signaling[J].Cell Death Differ,2022,29(5):946-960.
[17]张全利,施润,柏永康,等.MND1通过与KLF6结合形成MND1-KLF6-E2F1正反馈环加速细胞周期进程促进肺腺癌进展[J].癌症,2022,41(12):586-604.ZHANG QL,SHI R,BAI YK,et al.Meiotic nuclear divisions 1(MND1) fuels cell cycle progression by activating a KLF6/E2F1 positive feedback loop in lung adenocarcinoma[J].Cancer,2022,41(12):586-604.
[18] STOCKER M,LE NAIL LR,DE BELENET H,et al.Inhibition of p53-mediated cell cycle control as the determinant in dedifferentiated liposarcomas development[J].Am J Cancer Res,2021,11(6):3271-3284.
[19]MITHIEUX G.Transcription factor p63,a member of the p53 family of tumour suppressors,regulates hepatic glucose metabolism[J].Gut,2023,72(3):415-416.
[20]朱先玉,李江辉,毛苹苏.端粒DNA损伤修复机制及其意义[J].西南医科大学学报,2023,46(1):87-92.ZHU XY,LI JH,MIAO PS.Mechanism and significance of DNA damage repair in telomere[J].Journal of Southwest Medical University,2023,46(1):87-92.
[21] 张安妮,魏林飞,李宁,等.端粒和端粒酶在女性生殖健康中的作用[J].国际生殖健康/计划生育杂志,2023,42(2):145-149.ZHANG AN,WEI LF,LI N,et al.The role of telomeres and telomerase in female reproductive health[J].International Journal of Reproductive Health/Family Planning,2023,42(2):145-149.
[22] OHALI A,AVIGAD S,GOSHEN Y,et al.Alternative lengthening of telomeres(ALT) as a predominant mechanism of telomere maintenance in embryonal rhabdomyosarcoma[J].Cancer Research,2005,65:1148.
[23]CHO WN,DILLEY LR,LAMPSON AM,et al.Interchromosomal homology searches drive directional ALT telomere movement and synapsis[J].Cell,2014,159(1):108-121.
[24]ZHAO W,SUNG P.Significance of ligand interactions involving Hop2-Mnd1 and the RAD51 and DMC1 recombinases in homologous DNA repair and XX ovarian dysgenesis[J].Nucleic Acids Res,2015,43(8):4055-4066.
[25] LISA K,ANOEK F,LOUISE BV,et al.MND1 enables homologous recombination in somatic cells primarily outside the context of replication[J].Mol Oncol,2023,17(7):1192-1211.
[26] ALHENDI A,ROYLE N.The absence of(TCAGGG)n repeats in some telomeres,combined with variable responses to NR2F2 depletion,suggest that this nuclear receptor plays an indirect role in the alternative lengthening of telomeres[J].Sci Rep,2020,10(1):20597.
[27]FANG J,ZHEN J,GONG Y,et al.MND1 functions as a potential prognostic biomarker associated with cell cycle and immune infiltration in kidney renal clear cell carcinoma[J].Aging(Albany NY),2022,14(18):7416-7442.
[28] SENDINC E,SHI Y.RNA m6A methylation across the transcriptome[J].Mol Cell,2023,83(3):428-441.
[29] DASTSOOZ H,CEREDA M,DONNA D,et al.A comprehensive bioinformatics analysis of UBE2C in cancers[J].Int J Mol Sci,2019,20(9):2228.
[30]WENG W,YU L,LI Z,et al.The immune subtypes and landscape of sarcomas[J].BMC Immunol,2022,23(1):46.
[31] ZELCESKI A,FRANCICA P,LINGG L,et al.MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cells[J].Cell Rep,2023,42(5):112484.
[32]TAN K,WANG K,ZHAO A,et al.Meiotic nuclear divisions 1 promotes proliferation and metastasis in hepatocellular carcinoma and is a potential diagnostic and therapeutic target gene[J].Med Oncol,2022,40(1):14.
[33] SUN K,WANG D,ZHANG Z,et al.Columbianetin acetate inhibits the occurrence and development of pancreatic cancer cells by down-regulating the expression of Meiotic nuclear divisions 1[J].Biocell,2023,47(2):297-307.
[34] WEI J,MENG G,WU J,et al.Genetic network and gene set enrichment analyses identify MND1 as potential diagnostic and therapeutic target gene for lung adenocarcinoma[J].Sci Rep,2021,11(1):9430.
[35]CUI Z,WANG J,CHEN G,et al.The upregulation of CLGN in hepatocellular carcinoma is potentially regulated by hsa-miR-194-3p and associated with patient progression[J].Front Oncol,2023,12:1081510.
[36]BAO Z,CHENG J,ZHU J,et al.Using weighted gene co-expression network analysis to identify increased MND1 expression as a predictor of poor breast cancer survival[J].Int J Gen Med,2022,15:4959-4974.

Memo

Memo:
黑龙江省教育厅基本科研业务费基础研究(编号:2020-KYYWF-0283);口腔生物医学材料研发及个性化制造特色学科(编号:黑教联【2022】78号)
Last Update: 2024-09-30